DAFNA Capital Management LLC - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 147 filers reported holding VIKING THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,538,581
-25.7%
319,655
+8.9%
1.10%
-15.4%
Q2 2023$4,760,148
-10.4%
293,655
-8.0%
1.30%
-18.3%
Q1 2023$5,313,931
+8.4%
319,155
-38.8%
1.59%
+15.4%
Q4 2022$4,902,598
+226.2%
521,553
-5.6%
1.38%
+241.8%
Q3 2022$1,503,000
+12.5%
552,400
+19.5%
0.40%
+11.0%
Q2 2022$1,336,000
-0.4%
462,400
+3.4%
0.36%
+4.0%
Q1 2022$1,342,000
-34.8%
447,4000.0%0.35%
-32.4%
Q4 2021$2,058,000
-26.8%
447,4000.0%0.52%
-30.6%
Q3 2021$2,810,000
+4.9%
447,4000.0%0.75%
+33.2%
Q2 2021$2,680,000
-5.3%
447,4000.0%0.56%
-16.5%
Q1 2021$2,830,000
+10.2%
447,400
-1.9%
0.67%
-12.2%
Q4 2020$2,567,000
-2.2%
455,900
+1.1%
0.76%
-10.4%
Q3 2020$2,624,000
-19.3%
450,9000.0%0.85%
-9.1%
Q2 2020$3,251,000
+54.1%
450,9000.0%0.94%
+6.5%
Q1 2020$2,110,000
+25.7%
450,900
+115.5%
0.88%
+53.0%
Q4 2019$1,678,000
+16.6%
209,2000.0%0.58%
+6.5%
Q3 2019$1,439,000
-17.1%
209,2000.0%0.54%
-17.2%
Q2 2019$1,736,000
-2.5%
209,200
+16.7%
0.65%
-15.0%
Q1 2019$1,781,000
+29.9%
179,2000.0%0.77%
+12.6%
Q4 2018$1,371,000179,2000.68%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders